Who Buys Cabazitaxel from India — 107 Importers Behind a $9.2M Market
India's cabazitaxel import market is served by 107 active buyers who collectively imported $9.2M across 307 shipments. ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) leads with a 6.2% market share, followed by ACCORD HEALTHCARE ITALIA SRL. and MSN LABS CHILE SPA. The top 5 buyers together control 23.9% of total import value, reflecting a moderately competitive buyer landscape.
Top Cabazitaxel Importers — Ranked by Import Value
ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) is the leading cabazitaxel importer from India, holding a 6.2% share of the $9.2M market across 307 shipments from 107 buyers. The top 5 buyers — ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND), ACCORD HEALTHCARE ITALIA SRL. (ITALY), MSN LABS CHILE SPA (CHILE), ALLOGA FRANCE (NETHERLANDS), ACCORD HEALTHCARE, SLU (SPAIN) — collectively control 23.9% of total import value.
Top Cabazitaxel Buyers & Importers
Ranked by import value · 107 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE POLSKA SP. Z.O.O.POLAND CABAZITAXEL DR. REDDY'S 60MG/1.5ML1S ITPHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML( | $573.9K | 5 | 6.2% |
| 2 | ACCORD HEALTHCARE ITALIA SRL.ITALY CABAZITAXEL DR. REDDY'S 60MG/1.5ML1S ITPHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML( | $451.6K | 5 | 4.9% |
| 3 | MSN LABS CHILE SPACHILE XATIZA 60 -CL )XATIZA 60-CLNOSXATIZA 60 CABAZITAXEL INJ 60 MG/VIAL-CL | $439.6K | 5 | 4.8% |
| 4 | ALLOGA FRANCENETHERLANDS PHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML(PHR DRUGS&MEDI CABAZITAXEL 20MG/ML 3ML(A | $386.4K | 5 | 4.2% |
| 5 | ACCORD HEALTHCARE, SLUSPAIN CABAZITAXEL DR. REDDY'S 60MG/1.5ML1S ITPHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML( | $357.6K | 5 | 3.9% |
| 6 | ACCORD HEALTHCARE POLSKA SP. Z O.O.POLAND CABAZITAXEL DR. REDDY'S 60MG/1.5ML1S ITPHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML( | $295.8K | 5 | 3.2% |
| 7 | BROCACEF NL HUBNETHERLANDS PHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML(PHR DRUGS&MEDI CABAZITAXEL 20MG/ML 3ML(A | $275.7K | 5 | 3.0% |
| 8 | PHARMADOX HEALTHCARE LTDMALTA CABAZITAXEL 40MG/ML X1 ALVOGEN-ZENTIVACABAZITAXEL 60 MG FOR SOL X 1 UKMSN PHARMA CABAZITAXEL 40MG ML VIAL 60MG 1 5ML CZ SK 1 S | $263.2K | 5 | 2.9% |
| 9 | BROCACEF NL:HUBNETHERLANDS PHARMA DRUGS & MEDI CABAZITAXEL 20MG/MLPHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML(PHR DRUGS&MEDI CABAZITAXEL 20MG/ML 3ML(A | $228.4K | 5 | 2.5% |
| 10 | PHCEDEHOPALGERIA CABAZITAXEL INJ 60MG 1 5ML Z TEXEL 31 VIAL AS A FREE SAMPLE | $203.3K | 5 | 2.2% |
| 11 | PHARMADOX HEALTHCARE LIMITEDMALTA CABAZITAXEL 40MG/ML X1 ALVOGEN-ZENTIVACABAZITAXEL 60 MG FOR SOL X 1 UKMSN PHARMA CABAZITAXEL 40MG ML VIAL 60MG 1 5ML CZ SK 1 S | $159.8K | 5 | 1.7% |
| 12 | TILLOMED LABORATORIES LTDUNITED KINGDOM CABAZITAXEL 60MG FOR SOL X 1 UKCABAZITAXEL 40MG/ML X1 ALVOGEN-ZENTIVACABAZITAXEL 60 MG/1.5ML 1'S UK | $133.1K | 5 | 1.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Cabazitaxel — and from which countries?
Flow of Cabazitaxel exports from India: each country's share and the named importers behind the numbers
Cabazitaxel — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia emerges as the first largest importing country, achieving a total trade value of $2.4M through 0 shipments. This represents a market share of 25.7% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $2.4M, indicating premium pricing strategy compared to the market average of $30.1K.
Russia is a key market for Cabazitaxel imports, representing 25.7% of total trade value.
2Italy
Italy emerges as the second largest importing country, achieving a total trade value of $1.4M through 2 shipments. This represents a market share of 14.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Italy has a diverse importer base, with their top importers including:
• ACCORD HEALTHCARE ITALIA SRL. - $451.6K (33.0% of country's total business)
Key Insight: Italy demonstrates strong market positioning with an average shipment value of $683.2K, indicating premium pricing strategy compared to the market average of $30.1K.
Italy is a key market for Cabazitaxel imports, representing 14.8% of total trade value.
3Netherlands
Netherlands emerges as the third largest importing country, achieving a total trade value of $1.2M through 15 shipments. This represents a market share of 12.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• ALLOGA FRANCE - $386.4K (32.4% of country's total business)
• BROCACEF NL HUB - $275.7K (23.1% of country's total business)
• BROCACEF NL:HUB - $228.4K (19.2% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $79.4K, indicating premium pricing strategy compared to the market average of $30.1K.
Netherlands is a key market for Cabazitaxel imports, representing 12.9% of total trade value.
4Poland
Poland emerges as the fourth largest importing country, achieving a total trade value of $1.1M through 4 shipments. This represents a market share of 11.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Poland has a diverse importer base, with their top importers including:
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. - $573.9K (54.4% of country's total business)
• ACCORD HEALTHCARE POLSKA SP. Z O.O. - $295.8K (28.0% of country's total business)
Key Insight: Poland demonstrates strong market positioning with an average shipment value of $263.7K, indicating premium pricing strategy compared to the market average of $30.1K.
Poland is a key market for Cabazitaxel imports, representing 11.4% of total trade value.
5Malta
Malta emerges as the fifth largest importing country, achieving a total trade value of $788.4K through 44 shipments. This represents a market share of 8.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• PHARMADOX HEALTHCARE LTD - $263.2K (33.4% of country's total business)
• PHARMADOX HEALTHCARE LIMITED - $159.8K (20.3% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $17.9K, indicating competitive pricing strategy compared to the market average of $30.1K.
Malta is a key market for Cabazitaxel imports, representing 8.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Cabazitaxel buyer market intelligence
1Buyer Segment Analysis
The importation of Cabazitaxel from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like ACCORD HEALTHCARE POLSKA SP. Z.O.O. (Poland), ACCORD HEALTHCARE ITALIA SRL. (Italy), and ACCORD HEALTHCARE, SLU (Spain) function as intermediaries, procuring Cabazitaxel in bulk and supplying it to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as ALLOGA FRANCE (Netherlands) and PHARMADOX HEALTHCARE LTD (Malta) represent hospital networks that import Cabazitaxel directly for patient treatment. Their procurement is driven by patient demand and treatment schedules, leading to consistent, moderate-sized orders.
- Re-exporters: Companies like BROCACEF NL HUB (Netherlands) may act as re-exporters, importing Cabazitaxel for redistribution to other markets. Their buying behavior is influenced by international demand fluctuations, resulting in variable order sizes and frequencies.
The repeat buyer rate of 47.7% indicates a substantial proportion of buyers engage in ongoing procurement, reflecting sustained demand and the critical role of Cabazitaxel in oncology treatments.
Country-Specific Import Regulations
TransData Nexus Cabazitaxel buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the importation of Cabazitaxel involves specific regulatory processes:
- Russia:
- Regulatory Authority: Ministry of Health of the Russian Federation.
- Import Registration Process: Requires submission of a registration dossier, including clinical trial data and quality documentation.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Typically ranges from 5% to 10% for pharmaceuticals under HS Code 30049049.
- Italy:
- Regulatory Authority: Italian Medicines Agency (AIFA).
- Import Registration Process: Submission of a marketing authorization application, including product quality, safety, and efficacy data.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties under HS Code 30049049.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (MEB).
- Import Registration Process: Requires a marketing authorization application with comprehensive product information.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties under HS Code 30049049.
- Poland:
- Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.
- Import Registration Process: Submission of a registration dossier, including clinical and quality data.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties under HS Code 30049049.
- Malta:
- Regulatory Authority: Malta Medicines Authority.
- Import Registration Process: Requires a marketing authorization application with detailed product information.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties under HS Code 30049049.
Demand Drivers & Market Opportunity
TransData Nexus Cabazitaxel buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cabazitaxel in importing countries is primarily driven by the prevalence of metastatic castration-resistant prostate cancer (mCRPC), for which Cabazitaxel is a standard treatment. Government healthcare programs and the expansion of universal health coverage have increased access to such essential medicines. For instance, the inclusion of Cabazitaxel in national formularies and reimbursement schemes facilitates its availability to patients.
Additionally, the World Health Organization's Essential Medicines List (EML) influences procurement decisions, encouraging countries to prioritize the acquisition of listed medicines like Cabazitaxel. Tender-based purchasing mechanisms are commonly employed, allowing governments and healthcare institutions to procure Cabazitaxel at competitive prices, ensuring a steady supply to meet patient needs. The presence of 107 buyers across 49 countries underscores the global reliance on Cabazitaxel for effective cancer treatment.
Common Questions — Cabazitaxel Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest cabazitaxel buyer importing from India?
Based on import volume and value, ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) leads with $573.9K in imports and a 6.2% market share — the highest of any single cabazitaxel importer. ACCORD HEALTHCARE ITALIA SRL. (ITALY) and MSN LABS CHILE SPA (CHILE) are the next largest buyers.
QHow many companies buy cabazitaxel from India?
There are 107 active cabazitaxel buyers importing from India, with a combined market of $9.2M across 307 shipments to 49 countries. The top 5 buyers hold 23.9% of total import value, while the remaining 102 buyers handle the other 76.1%.
QWhich countries import the most cabazitaxel from India?
The top importing countries for cabazitaxel from India are Russia (25.7%), Italy (14.8%), Netherlands (12.9%), Poland (11.4%), Malta (8.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of cabazitaxel, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for cabazitaxel from India?
The average import transaction value for cabazitaxel from India is $30.1K, with an average unit price of $123.65 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Cabazitaxel buyer market intelligence
1Buyer Segment Analysis
The importation of Cabazitaxel from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like ACCORD HEALTHCARE POLSKA SP. Z.O.O. (Poland), ACCORD HEALTHCARE ITALIA SRL. (Italy), and ACCORD HEALTHCARE, SLU (Spain) function as intermediaries, procuring Cabazitaxel in bulk and supplying it to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as ALLOGA FRANCE (Netherlands) and PHARMADOX HEALTHCARE LTD (Malta) represent hospital networks that import Cabazitaxel directly for patient treatment. Their procurement is driven by patient demand and treatment schedules, leading to consistent, moderate-sized orders.
- Re-exporters: Companies like BROCACEF NL HUB (Netherlands) may act as re-exporters, importing Cabazitaxel for redistribution to other markets. Their buying behavior is influenced by international demand fluctuations, resulting in variable order sizes and frequencies.
The repeat buyer rate of 47.7% indicates a substantial proportion of buyers engage in ongoing procurement, reflecting sustained demand and the critical role of Cabazitaxel in oncology treatments.
Country-Specific Import Regulations
TransData Nexus Cabazitaxel buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the importation of Cabazitaxel involves specific regulatory processes:
- Russia:
- Regulatory Authority: Ministry of Health of the Russian Federation.
- Import Registration Process: Requires submission of a registration dossier, including clinical trial data and quality documentation.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Typically ranges from 5% to 10% for pharmaceuticals under HS Code 30049049.
- Italy:
- Regulatory Authority: Italian Medicines Agency (AIFA).
- Import Registration Process: Submission of a marketing authorization application, including product quality, safety, and efficacy data.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties under HS Code 30049049.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (MEB).
- Import Registration Process: Requires a marketing authorization application with comprehensive product information.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties under HS Code 30049049.
- Poland:
- Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.
- Import Registration Process: Submission of a registration dossier, including clinical and quality data.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties under HS Code 30049049.
- Malta:
- Regulatory Authority: Malta Medicines Authority.
- Import Registration Process: Requires a marketing authorization application with detailed product information.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties under HS Code 30049049.
Demand Drivers & Market Opportunity
TransData Nexus Cabazitaxel buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cabazitaxel in importing countries is primarily driven by the prevalence of metastatic castration-resistant prostate cancer (mCRPC), for which Cabazitaxel is a standard treatment. Government healthcare programs and the expansion of universal health coverage have increased access to such essential medicines. For instance, the inclusion of Cabazitaxel in national formularies and reimbursement schemes facilitates its availability to patients.
Additionally, the World Health Organization's Essential Medicines List (EML) influences procurement decisions, encouraging countries to prioritize the acquisition of listed medicines like Cabazitaxel. Tender-based purchasing mechanisms are commonly employed, allowing governments and healthcare institutions to procure Cabazitaxel at competitive prices, ensuring a steady supply to meet patient needs. The presence of 107 buyers across 49 countries underscores the global reliance on Cabazitaxel for effective cancer treatment.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 107 global importers of Cabazitaxel identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 307 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 49 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
307 Verified Shipments
107 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists